Chunye Huang
Nanchang, 330006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
A real-world study of Trifluridine/Tipiracil (TAS-102) combined with bevacizumab as the late-line treatment of metastatic colorectal cancer.
Journal: Discover oncology
Published: June 21, 2025
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion.
Journal: Cell communication and signaling : CCS
Published: October 12, 2024
TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer.
Journal: Cell death & disease
Published: October 10, 2024
MDM2 inhibitors in cancer immunotherapy: Current status and perspective.
Journal: Genes & diseases
Published: October 30, 2023
YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression.
Journal: Cellular and molecular life sciences : CMLS
Published: October 24, 2023
TMEM160 promotes tumor immune evasion and radiotherapy resistance via PD-L1 binding in colorectal cancer.
Journal: Cell communication and signaling : CCS
Published: October 21, 2023
Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment.
Journal: Molecular cancer
Published: December 09, 2022
FDFT1/FGFR2 rearrangement: A newly identified anlotinib-sensitive FGFR2 variant in cholangiocarcinoma.
Journal: Cancer treatment and research communications
Published: March 09, 2022
The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway.
Journal: Cell death discovery
Published: November 01, 2021
Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma.
Journal: OncoTargets and therapy
Published: May 28, 2020
Showing 1-12 of 12
Last Updated: 09/26/2026